Clinical trials
Phase 2/3 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2020 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aeris Therapeutics | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Daniels, Craig E., M.D. | 1 |
| Fudan University | 1 |
| Guangzhou JOYO Pharma Co., Ltd | 1 |
| Khon Kaen University | 1 |
| R-Pharm | 1 |
| R-Pharm International, LLC | 1 |
| The First Affiliated Hospital of Guangzhou Medical University | 1 |
| The University of Queensland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 15 |
| Respiratory Tract Diseases | 5 |
| Pathologic Processes | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| COVID-19 | 2 |
| Coronavirus Infections | 2 |
| Emphysema | 2 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Pulmonary Emphysema | 2 |
| Pulmonary Fibrosis | 2 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.